Hikma Pharmaceuticals PLC (HIK)
LSE
Real-time Data
07:00 AM
Day's Range
1,585.0052 wk Range
18.09Overview - HIK - Hikma Pharmaceuticals PLC
Key Statistics
Valuation
Enterprise Value
3.82B
P/E (Trailing)
‪12.40‬
P/E (Forward)
‪8.74‬
Price / Sales (TTM)
‪0.97‬
Price / Book
‪187.06‬
EV / EBITDA
‪5.89‬
Profitability
Profit Margin
‪11.31%‬
Operating Margin
‪23.49%‬
Return on Assets
‪7.46%‬
Return on Equity
‪15.40%‬
Ownership
Shares Outstanding
220.10M
Float
146.43M
Held by Insiders
‪32.95%‬
Held by Institutions
‪36.55%‬
Price stats
Beta
‪0.66‬
50-Day Avg
‪1,595.46‬
200-Day Avg
‪1,486.39‬
Dividends
Payout Ratio
‪46.87%‬
Frequency
Semi-Annual
Analyst Consensus
12 analysts
Average price target
‪£ 2,022.48‬Market Cap - HIK - Hikma Pharmaceuticals PLC
Peers - HIK - Hikma Pharmaceuticals PLC
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- HIKLSEHikma Pharmaceuticals PLC332.26BMarket Cap-8.04%52-week change12.41P/E (Trailing)‪11.31%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc308.38BMarket Cap-14.42%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB158.42BMarket Cap+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
- 0O14LSEMerck KGaA62.53BMarket Cap+20.64%52-week change19.12P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - HIK - Hikma Pharmaceuticals PLC
About
Hikma Pharmaceuticals PLC is a leading global pharmaceutical company specializing in the development, manufacturing, and distribution of high-quality generic, branded, and specialty medicines. Founded over 45 years ago, it focuses on making essential medications accessible, particularly through its extensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
